Thermo Fisher Scientific collaborates with TransMIT to promote MSI platform
Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues
Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues
Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity m system, which provides fast results in high volumes – detecting four infections simultaneously
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.
The country is sixth among the most affected countries by active cases
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
It works by collecting aerosols and identifies the presence of dangerous pathogens using sensitive, specific and rapid detection in near-real time without laboratory analysis
The company has decided to transfer our rights in relation to the lodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited
Subscribe To Our Newsletter & Stay Updated